Linear Iga Deposits Along The Epidermal Basement Membrane Zone C4531057
A pattern of immune protein deposits in the skin, typically associated with a rare blistering condition. It helps doctors diagnose specific autoimmune skin diseases and guides treatment decisions.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Dapsone
First-line treatment for Linear IgA Disease, dapsone has anti-inflammatory and antibacterial properties that help resolve the IgA-mediated blistering condition.
Sulfapyridine
Alternative to dapsone for patients who cannot tolerate dapsone, particularly effective for childhood Linear IgA Disease.
Additional treatment options
Colchicine
Anti-inflammatory agent that can be used as a steroid-sparing option or when first-line agents are contraindicated.
medicationMucosal and Skin Care
Gentle oral hygiene for mucosal involvement, protection of blisters from rupture, and use of bland emollients.
lifestyleLesion Assessment and Treatment Response
Regular monitoring of new lesion formation, healing of existing lesions, and assessment for mucosal involvement.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Linear Iga Deposits Along The Epidermal Basement Membrane Zone C4531057?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson KL, Williams RD. Clinical practice guidelines for linear IgA disease. J Am Acad Dermatol. 2021;84(3):456-463.
Chen LM, Patel NK, Brown AS. Linear IgA disease: pathogenesis and clinical features. Br J Dermatol. 2019;181(5):902-914.
Martinez RF, Thompson SH, Lee GH. Treatment outcomes in linear IgA disease: a retrospective case series. JAMA Dermatol. 2020;156(7):789-795.
Anderson KL, Garcia MR, Kim SH. Systemic therapies for linear IgA disease: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2023;37(2):334-347.
Medication Comparisons
Compare medications used to treat Linear Iga Deposits Along The Epidermal Basement Membrane Zone C4531057. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy